Clinical Trials Browser

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Endometrial Neoplasms

Endometrial Stromal Tumors

Endometrial Neoplasms

Endometrial Neoplasms

Low-Grade Serous Ovarian Cancer

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Endometrial Neoplasms

Recurrence, Endometrial Neoplasms

Endometrial Neoplasms

Endometrial Endometrioid Adenocarcinoma

Progesterone Resistance, Endometrial Hyperplasia, Endometrial Neoplasms

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Ovarian Neoplasms, Endometrial Neoplasms

Endometrial Neoplasms

Low Grade Serous Ovarian Carcinoma

Carcinoma, Ovarian Epithelial

Carcinoma, Ovarian Epithelial

Ovarian Neoplasms

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Ovarian Neoplasms

Ovarian Neoplasms

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Ovarian Cysts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Neoplasms

Leiomyosarcoma, Uterine Neoplasms

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

EndoMAP

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

FEMUS

BFR-ESS

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

ALPINE: Maintenance Letrozole/Abemaciclib

CHAMELEON

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

ALEPRO

MITO32

LEPRE

IMPACT

LIBER

Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

SMMART Adaptive Clinical Treatment (ACT) Trial

The Role of Estrogen in Luteinizing Hormone Surge and Ovulation

Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Letrozole as a Treatment of Endometrial Cancer

Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

TGOG1005

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Letrozole in Patients With Ovarian Tumors